Related Experiment Videos
Can receptors be imaged with MRI agents?
A D Nunn1, K E Linder, M F Tweedle
1Ernst Felder Laboratories, Bracco Research USA Inc., Princeton, New Jersey 08540, USA.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|June 1, 1997
Summary
Imaging biochemical receptors is feasible with current compounds, but biological delivery and saturation present challenges. Enhancing contrast agents and targeting specific receptor pathways can overcome these limitations for potential clinical applications.
Area of Science:
- Biomedical imaging
- Molecular imaging
- Receptor imaging
Background:
- Classical biochemical receptors are crucial targets for molecular imaging.
- Current imaging techniques face limitations in receptor visualization.
- Understanding these limitations is key to developing advanced imaging agents.
Purpose of the Study:
- To review the feasibility of imaging classical biochemical receptors.
- To identify physical and biological limitations in receptor imaging.
- To explore strategies for overcoming these limitations.
Main Methods:
- Literature review of published studies on receptor imaging.
- Analysis of physical and biological constraints.
- Evaluation of contrast agent properties and targeting strategies.
Main Results:
- No fundamental physical limitations exist for imaging receptors with current compounds.
- Biological constraints, including contrast agent delivery and receptor saturation, are significant hurdles.
- Improving contrast agent relaxivity and targeting accessible receptors can mitigate these issues.
Conclusions:
- Receptor imaging is physically feasible, with biological factors posing the primary challenges.
- Strategies like enhanced contrast agents and targeted delivery are crucial for clinical success.
- Future targeted MRI agents may offer different clinical utility compared to radiopharmaceuticals.